Register to chat with like-minded investors on our interactive forums.
Medical
Antares Pharma ($ATRS) Quietly Being Accumulated, Set Up For Breakout
Mar 22 2013 @ 09:41
Antares Pharma (ATRS) is being set up to run to at least $3.85, Thesis follows below; The chart above shows “quiet”...
Obagi Acquired by Valeant, Are There Other Biotech Acquisitions Coming?
Mar 21 2013 @ 13:11
Yesterday, Obagi Medical Products (OMPI) was acquired by Valeant Pharmaceuticals (VRX) for $19.75 a share in an all...
Significant Catalysts And Company PR Error Present Significant Opportunity In AcelRx Pharmaceuticals
Mar 17 2013 @ 20:24
By Scott Matusow twitter.com/scottmatusow With The positive result of the first phase III study, coupled with the...
AcelRx Pharma Selloff Caused By Error In Recent Press Release
Mar 15 2013 @ 13:29
On March 12th, Acelrx (ACRX) released a pr covering its last quarter’s earnings. In the pr, the company stated...
AcelRx Pharma Poised to Move Higher on Technicals and Latest News
Mar 06 2013 @ 11:44
$ACRX Trade Call – Target $5.75 Yesterday, AcelRX said its Sufentanil NanoTab patient-controlled analgesia (PCA...
New MSRA Treatment Could Bring Billions In Revenues
Mar 04 2013 @ 13:12
Trius Therapeutics (TSRX) Trius is expecting top-line data from its 2nd Phase III trial of Tedizolid (TR-701...
Will 2013 Be The Year For MultiCell Technologies?
Feb 25 2013 @ 14:05
MultiCell Technologies, Inc. (MCET) is a biopharmaceutical company, engaged in the research, development, and...
Cyclacel Pharmaceuticals offers a nice catalyst trade opportunity
Feb 20 2013 @ 08:05
Cyclacel Pharmaceuticals (NASDAQ: CYCC) is expecting safety data and full myelodysplastic syndromes (MDS) data by...
Will Medical Marijuana Inc. Soar in 2013?
Feb 16 2013 @ 16:44
Medical Marijuana, Inc. (MJNA.PK) operates in the medical marijuana and industrial hemp markets. Its products range...
Carl Icahn Backs Herbalife
Feb 15 2013 @ 11:07
Herbalife (NYSE:HLF) is up more than 11% in today’s trading session after Carl Icahn revealed that he...
